David E. Anderson

634 total citations
21 papers, 328 citations indexed

About

David E. Anderson is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, David E. Anderson has authored 21 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Immunology and 5 papers in Hepatology. Recurrent topics in David E. Anderson's work include Immunotherapy and Immune Responses (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Hepatitis B Virus Studies (5 papers). David E. Anderson is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Hepatitis B Virus Studies (5 papers). David E. Anderson collaborates with scholars based in United States, Canada and United Kingdom. David E. Anderson's co-authors include Yvonne Perrie, Jitinder Wilkhu, Sarah E. McNeil, Francisco Díaz‐Mitoma, José V. Torres, Marc Kirchmeier, Anne-Catherine Fluckiger, Tanvir Ahmed, Ali Azizi and Masoud Ghorbani and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Journal of Hepatology.

In The Last Decade

David E. Anderson

20 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Anderson United States 10 118 105 103 86 72 21 328
Sompong Sapsutthipas Thailand 10 32 0.3× 174 1.7× 97 0.9× 87 1.0× 25 0.3× 21 319
Brian Vandahl Denmark 7 92 0.8× 82 0.8× 148 1.4× 167 1.9× 13 0.2× 7 445
Marie-Claude Bonnet France 11 107 0.9× 163 1.6× 101 1.0× 204 2.4× 11 0.2× 15 457
Toshiki Sekiya Japan 9 114 1.0× 64 0.6× 70 0.7× 121 1.4× 15 0.2× 18 287
Marianna Taccone Italy 7 138 1.2× 107 1.0× 216 2.1× 282 3.3× 25 0.3× 8 465
Anna Figueiredo United States 6 85 0.7× 130 1.2× 98 1.0× 51 0.6× 36 0.5× 11 324
Fengmin Zhou United States 9 118 1.0× 92 0.9× 85 0.8× 192 2.2× 17 0.2× 15 354
G A Van Nest United States 8 144 1.2× 81 0.8× 163 1.6× 211 2.5× 14 0.2× 9 463
Natasha Dubois Cauwelaert United States 10 153 1.3× 142 1.4× 106 1.0× 202 2.3× 10 0.1× 14 403
Deborah King United Kingdom 13 59 0.5× 103 1.0× 114 1.1× 134 1.6× 7 0.1× 25 400

Countries citing papers authored by David E. Anderson

Since Specialization
Citations

This map shows the geographic impact of David E. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Anderson more than expected).

Fields of papers citing papers by David E. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Anderson. The network helps show where David E. Anderson may publish in the future.

Co-authorship network of co-authors of David E. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Anderson. A scholar is included among the top collaborators of David E. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Anderson. David E. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langley, Joanne M., Soren Gantt, Scott A. Halperin, et al.. (2023). An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study. Vaccine. 42(3). 713–722. 11 indexed citations
2.
Iwamoto, Fábio M., Neel I. Nissen, David A. Reardon, et al.. (2023). CTIM-27. PERIPHERAL BIOMARKER ANALYSIS OF T CELL-MEDIATED COLLAGEN REMODELING CORRELATES WITH TUMOR RESPONSES IN A PHASE IIA TRIAL OF VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901). Neuro-Oncology. 25(Supplement_5). v68–v68. 2 indexed citations
3.
Vesikari, Timo, Joanne M. Langley, Johanna N. Spaans, et al.. (2023). The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine. Vaccine. 41(24). 3584–3588. 9 indexed citations
4.
5.
6.
Fluckiger, Anne-Catherine, Tanvir Ahmed, Tamara Berthoud, et al.. (2021). An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity. Vaccine. 39(35). 4988–5001. 31 indexed citations
7.
Wen, Patrick Y., David A. Reardon, Deborah Forst, et al.. (2021). Evaluation of GM-CSF and AS01B adjuvants in a phase I/IIa trial of a therapeutic CMV vaccine (VBI-1901) against recurrent glioblastoma (GBM).. Journal of Clinical Oncology. 39(15_suppl). 2047–2047. 3 indexed citations
8.
9.
Lassman, Andrew B., David A. Reardon, Eudocia Q. Lee, et al.. (2019). Interim results of a phase I/IIa trial of a therapeutic CMV vaccine against recurrent glioblastoma (GBM).. Journal of Clinical Oncology. 37(15_suppl). 2048–2048. 2 indexed citations
10.
Gantt, Soren, Caroline Quach, David E. Anderson, Francisco Díaz‐Mitoma, & Joanne M. Langley. (2018). LB18. An Enveloped Virus-like Particle (eVLP) Cytomegalovirus (CMV) Vaccine Is Immunogenic and Safe: Results of a First-in-Humans Study. Open Forum Infectious Diseases. 5(suppl_1). S765–S765. 3 indexed citations
11.
Wilkhu, Jitinder, Sarah E. McNeil, David E. Anderson, Marc Kirchmeier, & Yvonne Perrie. (2017). Development of a solid dosage platform for the oral delivery of bilayer vesicles. European Journal of Pharmaceutical Sciences. 108. 71–77. 20 indexed citations
12.
Ahmed, Tanvir, et al.. (2016). IMST-31. CMV gB/pp65 eVLPs FORMULATED WITH GM-CSF AS A THERAPEUTIC VACCINE AGAINST GBM AND MEDULLOBLASTOMA. Neuro-Oncology. 18(suppl_6). vi93–vi93. 2 indexed citations
13.
Wilkhu, Jitinder, Sarah E. McNeil, David E. Anderson, & Yvonne Perrie. (2013). Characterization and optimization of bilosomes for oral vaccine delivery. Journal of drug targeting. 21(3). 291–299. 74 indexed citations
14.
Wilkhu, Jitinder, Sarah E. McNeil, David E. Anderson, & Yvonne Perrie. (2013). Consideration of the efficacy of non-ionic vesicles in the targeted delivery of oral vaccines. Drug Delivery and Translational Research. 4(3). 233–245. 8 indexed citations
15.
Kang, Kyung Hee, Yasuhiro Yamamura, Maria P. Carlos, et al.. (2010). Synthetic Antigens Representing the Antigenic Variation of Human Hepatitis C Virus. Viral Immunology. 23(5). 497–508. 1 indexed citations
16.
Azizi, Ali, David E. Anderson, José V. Torres, et al.. (2008). Induction of Broad Cross-Subtype-Specific HIV-1 Immune Responses by a Novel Multivalent HIV-1 Peptide Vaccine in Cynomolgus Macaques. The Journal of Immunology. 180(4). 2174–2186. 27 indexed citations
17.
Azizi, Ali, David E. Anderson, Masoud Ghorbani, Katrina Gee, & Francisco Díaz‐Mitoma. (2006). Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters. BMC Immunology. 7(1). 25–25. 8 indexed citations
18.
Ghorbani, Masoud, Théo Nass, Ali Azizi, et al.. (2005). Comparison of Antibody- and Cell-Mediated Immune Responses After Intramuscular Hepatitis C Immunizations of BALB/c Mice. Viral Immunology. 18(4). 637–648. 10 indexed citations
19.
Anderson, David E., Maria P. Carlos, Lynn Nguyen, & José V. Torres. (2001). Overcoming Original (Antigenic) Sin. Clinical Immunology. 101(2). 152–157. 17 indexed citations
20.
Torres, José V., Arthur Malley, Babak Banapour, et al.. (1993). An Epitope on the Surface Envelope Glycoprotein (gp130) of Simian Immunodeficiency Virus (SIV mac ) Involved in Viral Neutralization and T Cell Activation. AIDS Research and Human Retroviruses. 9(5). 423–430. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sompong Sapsutthipas Breakdown of academic impact, for papers by Brian Vandahl Breakdown of academic impact, for papers by Marie-Claude Bonnet Breakdown of academic impact, for papers by Toshiki Sekiya Breakdown of academic impact, for papers by Marianna Taccone Breakdown of academic impact, for papers by Anna Figueiredo Breakdown of academic impact, for papers by Fengmin Zhou Breakdown of academic impact, for papers by G A Van Nest Breakdown of academic impact, for papers by Natasha Dubois Cauwelaert Breakdown of academic impact, for papers by Deborah King
Rankless by CCL
2026